Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia

被引：1

作者：

Hills, Thomas ^{[1
]}

Delaney, Anthony ^{[2
]}

Young, Paul J. ^{[1
]}

机构：

[1] Med Res Inst New Zealand, Wellington, New Zealand

[2] George Inst Global Hlth, Newtown, NSW, Australia

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 390卷 / 08期

关键词：

D O I：

10.1056/NEJMc2400427

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To the Editor: Ehrmann et al. (Nov. 30 issue)(1) found, in the Inhaled Amikacin vs. Placebo to Prevent Ventilator Associated Pneumonia (AMIKINHAL) trial, that among adults who had undergone mechanical ventilation for at least 3 days, a subsequent 3-day course of inhaled amikacin reduced the incidence of ventilator-associated pneumonia. The use of a low suspicion threshold for reporting possible cases of ventilator-associated pneumonia resulted in a higher incidence of disease in the control group (22%) than anticipated in the sample-size calculation (12%) and may have identified cases that were not clinically consequential. In addition, there are limitations to using bacterial . . .

引用

页码：769 / 770

页数：2

共 50 条

[21] BUNDLE TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA: A COLLECTIVE CONSTRUCTION
da Silva, Sabrina Guterres
Pereira do Nascimento, Eliane Regina
de Salles, Raquel Kuerten
TEXTO & CONTEXTO ENFERMAGEM, 2012, 21 (04) : 837 - 844
[22] Ventilator-Associated Pneumonia: Easy to Prevent or Hard to Define?
Steward, Sarah
Muszynski, Jennifer A.
PEDIATRIC CRITICAL CARE MEDICINE, 2016, 17 (05) : 469 - 470
[23] Bundles to prevent ventilator-associated pneumonia: how valuable are they?
Wip, Charity
Napolitano, Lena
CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (02) : 159 - 166
[24] Continuous lateral rotation therapy to prevent ventilator-associated pneumonia: The neglected effects of gravity on pathogenesis of ventilator-associated pneumonia
Berra, Lorenzo
Cressoni, Massimo
Li Bassi, Gianluigi
Kolobow, Theodor
Panigada, Mauro
Zanella, Alberto
CRITICAL CARE MEDICINE, 2010, 38 (03) : 1018 - 1019
[25] Nebulized Ceftazidime and Amikacin in Ventilator-associated Pneumonia Caused by Pseudomonas aeruginosa
Lu, Qin
Yang, Jianxin
Liu, Zhihai
Gutierrez, Claudia
Aymard, Guy
Rouby, Jean-Jacques
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (01) : 106 - 115
[26] Inhaled therapy and ventilator-associated pneumonia: A breath of suspicion in the air?
Clavel, Marc
CRITICAL CARE MEDICINE, 2011, 39 (04) : 893 - 894
[27] OUTCOMES COMPARING INHALED AND INTRAVENOUS TOBRAMYCIN IN VENTILATOR-ASSOCIATED PNEUMONIA
Garber, Paige
Droege, Chris
Mueller, Eric
Ernst, Neil
Droege, Molly
CRITICAL CARE MEDICINE, 2016, 44 (12)
[28] Inhaled Antibiotics for Hospital-Acquired and Ventilator-Associated Pneumonia
Daniels, Lindsay M.
Juliano, Jonathan
Marx, Ashley
Weber, David J.
CLINICAL INFECTIOUS DISEASES, 2017, 64 (03) : 386 - 387
[29] From ventilator-associated tracheobronchitis to ventilator-associated pneumonia
Martin-Loeches, I.
Nseir, S.
Valles, J.
Artigas, A.
REANIMATION, 2013, 22 (03): : 231 - 237
[30] Prevention of Ventilator-Associated Pneumonia and Ventilator-Associated Conditions
Mishra, Shakti Bedanta
Azim, Afzal
Muzzafar, Syed Nabeel
CRITICAL CARE MEDICINE, 2015, 43 (11) : E527 - E528

← 1 2 3 4 5 →